Showing posts with label YM Biosciences. Show all posts
Showing posts with label YM Biosciences. Show all posts

Thursday, August 18, 2011

Alcoa (AA) (YMI) (CRM) (EXEL) (GCO) (HS) Get New Coverage

Alcoa Inc. (NYSE: AA), YM BioSciences Inc. (NYSE: YMI), Salesforce.com (NYSE: CRM), Exelixis, Inc. (NASDAQ: EXEL), Genesco Inc (NYSE: GCO) and HealthSpring, Inc. (NYSE: HS) getting new analyst coverage.

Collins Stewart initiated coverage on YM BioSciences Inc. (YMI). They placed a “Buy” rating and a price target of $4.00 on the company.

CRT Capital initiated coverage on Alcoa Inc. (AA). They placed a “Buy” rating on the company.

Sanford C. Bernstein initiated coverage on Salesforce.com (CRM). They placed an “Underperform” rating on the company.

Stifel Nicolaus initiated coverage on Exelixis, Inc. (EXEL). They placed a “Hold” rating and a price target of $8.00 on the company.

Avondale Partners initiated coverage on Genesco Inc. (GCO). They placed an “Outperform” rating and a price target of $55.00 on the company.

Wells Fargo & Co. (NYSE:WFC) initiated coverage on HealthSpring, Inc (HS). They placed an “Outperform” rating on the company.